Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Recruiting · NCT07703683 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population. .
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Metabolic or endocrine disease
Exclusion criteria
- Known myopathy
- Systemic steroid use (\> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome
- Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol
- History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor
Where it is running
1 location listed.
- Cliniques Universitaires Saint-Luc - Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, Belgium